Medtronic Announces Preliminary PRODIGY Results: a Global Study to Identify Patients at High Risk for Opioid-Induced Respiratory Compromise
(WorldNews Africa)

(GLOBE NEWSWIRE via COMTEX) --Groundbreaking Microstream(TM) Capnography Study Provides Easy-to-Use Risk Prediction Tool Study Found Greater Than 40 Percent of Patients on Hospital General Care Floor Experience Opioid- Induced Respiratory Depression DUBLIN and SAN DIEGO - February 17, 2019 - Medtronic plc (NYSE:MDT) today announced preliminary results from PRODIGY, a Medtronic-sponsored, prospective, multi-center study to identify people at high risk for opioid-induced respiratory depression (OIRD), a form of respiratory compromise. Study results demonstrated that investigators were able to develop an easy-to-use risk prediction tool to identify patients at high risk of developing...